ESC Premium Access

Novel Approaches to Lipid Lowering Therapy

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Lipid-Lowering Agents
Session type: Advances in Science
Date: 31 August 2020
Time: 10:50 - 11:20

Session

3 presentations in this session

RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency

Speaker: Professor C. Ballantyne (Houston, US)
Thumbnail

RNAi inhibition of angiopoietin-like protein 3 (ANGPTL3) with ARO-ANG3 mimics the lipid and lipoprotein profile of familial combined hypolipidemia

Speaker: Professor G. Watts (Perth, AU)
Thumbnail

Correlation between different LDL-R mutations and response to ab-PCSK9 therapy in a group of patient with genetic diagnosis of Familial Hypercholesterolemia. Preliminary report.

Speaker: Doctor A. buonaiuto (Naples, IT)
Thumbnail

3 speakers from this session

Professor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)
16 presentations
1 follower

Professor Gerald Watts

University of Western Australia, Perth (Australia)
0 follower

Doctor Alessio buonaiuto

ASL Napoli 1 Centre, Naples (Italy)
0 follower

This platform is supported by

logo Novo Nordisk